<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38025440</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-0640</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in psychiatry</Title><ISOAbbreviation>Front Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Prevalence and incidence of neuropsychiatric disorders in post hospitalized COVID-19 patients in South America: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1163989</StartPage><MedlinePgn>1163989</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1163989</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpsyt.2023.1163989</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">There are multiple reports of neuropsychiatric disorders (NDs) such as stress, depression, post-traumatic stress disorder (PTSD), or anxiety, in patients who have survived the acute phase of COVID-19, being even more frequent in people who were hospitalized with moderate or severe disease. South America (SA) was one of the most affected continents during this time due to its health, social, political and economic context. We aimed to determine the prevalence and incidence of NDs in patients following hospitalization for COVID-19 in SA.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">We searched in PubMed, Embase, Scopus, Web of Science, LILACS, SciELO, and Google Scholar databases up to October 2022. We performed proportion meta-analysis with a random-effect model and Freeman-Tukey Double Arcsine transformation using the STATA 16.1 program. Finally, we evaluated heterogeneity by subgroup analysis and certainty of evidence with the GRADE approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We included eight studies from four countries. We only pooled six studies with prevalence measures. The estimated prevalence of all NDs was 31.48% (two-studies, 95%CI: 25.82-37.43). Depression, anxiety, insomnia, PTSD, and memory alterations had a pooled prevalence of 16.23% (three-studies, 95%CI: 7.18-27.93, I2: 94.22), 18.72% (three-studies, 95%CI: 11.65-26.97, I2: 87.56), 43.07% (three-studies, 95%CI: 32.77-53.37, I2: 92.61), 31.78% (three-studies, 95%CI: 14.33-52.40, I2: 97.96), and 38.24% (two-studies, 95%CI: 35.5-40.97), respectively. The evidence included was deemed as moderate to high certainty.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We suggest that NDs should be prioritized in research and care in South America with public policies that can support their identification and prompt management to improve the quality of life of patients. More studies are needed to adequately study the prevalence of NDs in South America, their associated factors, and evaluate the causes of heterogeneity.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://doi.org/10.6084/m9.figshare.21901041.v1.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Perea-Fl&#xf3;rez, Javier-Murillo, Lapeyre-Rivera, Gamonal, Cabanillas-Lazo, Vel&#xe1;squez-Rimachi and Alva-Diaz.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perea-Fl&#xf3;rez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Facultad de Medicina Humana, Universidad de Piura, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sociedad Cient&#xed;fica de la Universidad de Piura, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Red de Eficacia Cl&#xed;nica y Sanitaria, REDECS, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javier-Murillo</LastName><ForeName>Nair</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Facultad de Medicina Humana, Universidad de Piura, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sociedad Cient&#xed;fica de la Universidad de Piura, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Red de Eficacia Cl&#xed;nica y Sanitaria, REDECS, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapeyre-Rivera</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Red de Eficacia Cl&#xed;nica y Sanitaria, REDECS, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sociedad Cient&#xed;fica de San Fernando, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamonal</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Facultad de Medicina Humana, Universidad de Piura, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sociedad Cient&#xed;fica de la Universidad de Piura, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Red de Eficacia Cl&#xed;nica y Sanitaria, REDECS, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabanillas-Lazo</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Red de Eficacia Cl&#xed;nica y Sanitaria, REDECS, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sociedad Cient&#xed;fica de San Fernando, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vel&#xe1;squez-Rimachi</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Neurociencia, Efectividad Cl&#xed;nica y Salud P&#xfa;blica, Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alva-Diaz</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Red de Eficacia Cl&#xed;nica y Sanitaria, REDECS, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina de la Universidad Se&#xf1;or de Sip&#xe1;n, Chiclayo, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Medicina y Oficina de Apoyo a la Docencia e Investigaci&#xf3;n (OADI), Servicio de Neurolog&#xed;a, Hospital Daniel Alcides Carri&#xf3;n, Callao, Peru.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.21901041.v1</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Psychiatry</MedlineTA><NlmUniqueID>101545006</NlmUniqueID><ISSNLinking>1664-0640</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">South America</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">neuropsychiatric</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">post-hospitalized</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>16</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38025440</ArticleId><ArticleId IdType="pmc">PMC10646553</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2023.1163989</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO)  (2023). Coronavirus (COVID-19) dashboard. Available at: https://covid19.who.int (Accessed February 10, 2023).</Citation></Reference><Reference><Citation>The Lancet Null . COVID-19 in Latin America-emergency and opportunity. Lancet Lond Engl. (2021) 398:93. doi: 10.1016/S0140-6736(21)01551-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01551-8</ArticleId><ArticleId IdType="pmc">PMC8266269</ArticleId><ArticleId IdType="pubmed">34246349</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. (2021) 72:384&#x2013;96. doi: 10.33588/rn.7211.2021230, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.33588/rn.7211.2021230</ArticleId><ArticleId IdType="pubmed">34042167</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  (2023). Coronavirus disease (COVID-19): post COVID-19 condition. Available at: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition (Accessed February 10, 2023).</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)  (2022). Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years&#x2014;United States, March 2020&#x2013;November 2021. https://www.cdc.gov/mmwr/volumes/71/wr/mm7121e1.htm (Accessed February 10, 2023).</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)  (2023). Post-COVID conditions. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (Accessed August 22, 2023).</Citation></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. . Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. (2020) 89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. (2021) 8:130&#x2013;40. doi: 10.1016/S2215-0366(20)30462-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, et al. . Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. (2022) 4:fcab297. doi: 10.1093/braincomms/fcab297, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampogna G, di Vincenzo M, Giallonardo V, Perris F, Volpicelli A, del Vecchio V, et al. . The psychiatric consequences of long-COVID: a scoping review. J Pers Med. (2022) 12:1767. doi: 10.3390/jpm12111767, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12111767</ArticleId><ArticleId IdType="pmc">PMC9697474</ArticleId><ArticleId IdType="pubmed">36579511</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N, Zhao Y-M, Yan W, Li C, Lu Q-D, Liu L, et al. . A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. (2023) 28:423&#x2013;33. doi: 10.1038/s41380-022-01614-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. (2022) 434:120162. doi: 10.1016/j.jns.2022.120162, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19&#x2014;a systematic review. Brain Behav Immun. (2021) 97:328&#x2013;48. doi: 10.1016/j.bbi.2021.07.018, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. (2009) 339:b2535. doi: 10.1136/bmj.b2535, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos WMD, Secoli SR, P&#xfc;schel VAA. The Joanna Briggs institute approach for systematic reviews. Rev Lat Am Enfermagem. (2018) 26:e3074. doi: 10.1590/1518-8345.2885.3074</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1518-8345.2885.3074</ArticleId><ArticleId IdType="pmc">PMC6248737</ArticleId><ArticleId IdType="pubmed">30462787</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. (1950) 21:607&#x2013;11. doi: 10.1214/aoms/1177729756</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/aoms/1177729756</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. (1986) 7:177&#x2013;88. doi: 10.1016/0197-2456(86)90046-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. (2013) 67:974&#x2013;8. doi: 10.1136/jech-2013-203104, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2013-203104</ArticleId><ArticleId IdType="pubmed">23963506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, et al. . The GRADE working group clarifies the construct of certainty of evidence. J Clin Epidemiol. (2017) 87:4&#x2013;13. doi: 10.1016/j.jclinepi.2017.05.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2017.05.006</ArticleId><ArticleId IdType="pmc">PMC6542664</ArticleId><ArticleId IdType="pubmed">28529184</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;eda MER, Espinoza HSC. Factores relacionados con el estr&#xe9;s postraum&#xe1;tico en pacientes con alta m&#xe9;dica por la COVID-19. Rev Cuba Med Mil. (2022) 51:02202128.</Citation></Reference><Reference><Citation>Rojas C&#xe1;rdenas C, Noguera Ramos VE, Fl&#xf3;rez Jurado C, P&#xe1;ez Prieto JL, Sanjuan Ganem M, Ortiz Acevedo R, et al. . Chronic care for patients with post-COVID-19 syndrome after discharge from an intensive care unitCuidados prolongados de pacientes com s&#xed;ndrome p&#xf3;s-COVID-19 ap&#xf3;s interna&#xe7;&#xe3;o em unidade de terapia intensiva. Educ Med Salud. (2022) 46:e43. doi: 10.26633/RPSP.2022.43, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.26633/RPSP.2022.43</ArticleId><ArticleId IdType="pmc">PMC9128664</ArticleId><ArticleId IdType="pubmed">35620174</ArticleId></ArticleIdList></Reference><Reference><Citation>Huarcaya-Victoria J, Alarcon-Ruiz CA, Barzola-Farf&#xe1;n W, Cruzalegui-Baz&#xe1;n C, Cabrejos-Espinoza M, Aspilcueta-Montoya G, et al. . One-year follow-up of depression, anxiety, and quality of life of Peruvian patients who survived COVID-19. Qual Life Res. (2023) 32:139&#x2013;49. doi: 10.1007/s11136-022-03208-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-022-03208-w</ArticleId><ArticleId IdType="pmc">PMC9358105</ArticleId><ArticleId IdType="pubmed">35939252</ArticleId></ArticleIdList></Reference><Reference><Citation>Todt BC, Szlejf C, Duim E, Linhares AOM, Kogiso D, Varela G, et al. . Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge. Respir Med. (2021) 184:106453&#x2013;3. doi: 10.1016/j.rmed.2021.106453, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106453</ArticleId><ArticleId IdType="pmc">PMC8116128</ArticleId><ArticleId IdType="pubmed">34010740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira JC, Moreira TCL, de Ara&#xfa;jo AL, Imamura M, Damiano RF, Garcia ML, et al. . Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome. J Glob Health. (2022) 12:05029. doi: 10.7189/jogh.12.05029, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05029</ArticleId><ArticleId IdType="pmc">PMC9359428</ArticleId><ArticleId IdType="pubmed">35939273</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Caruso MJG, Cincoto AV, de Almeida Rocca CC, de P&#xe1;dua Serafim A, Bacchi P, et al. . Post-COVID-19 psychiatric and cognitive morbidity: preliminary findings from a Brazilian cohort study. Gen Hosp Psychiatry. (2022) 75:38&#x2013;45. doi: 10.1016/j.genhosppsych.2022.01.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.01.002</ArticleId><ArticleId IdType="pmc">PMC8734055</ArticleId><ArticleId IdType="pubmed">35134702</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistella LR, Imamura M, de Pretto LR, van Cauwenbergh SKHAA, Delgado Ramos V, Saemy Tome Uchiyama S, et al. . Long-term functioning status of COVID-19 survivors: a prospective observational evaluation of a cohort of patients surviving hospitalisation. BMJ Open. (2022) 12:e057246. doi: 10.1136/bmjopen-2021-057246, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057246</ArticleId><ArticleId IdType="pmc">PMC9334693</ArticleId><ArticleId IdType="pubmed">35896292</ArticleId></ArticleIdList></Reference><Reference><Citation>Henr&#xed;quez-Beltr&#xe1;n M, Labarca G, Cigarroa I, Enos D, Lastra J, Nova-Lamperti E, et al. . Sleep health and the circadian rest-activity pattern four months after COVID-19. J Bras Pneumol. (2022) 48:e20210398. doi: 10.36416/1806-3756/e20210398</Citation><ArticleIdList><ArticleId IdType="doi">10.36416/1806-3756/e20210398</ArticleId><ArticleId IdType="pmc">PMC9064633</ArticleId><ArticleId IdType="pubmed">35508066</ArticleId></ArticleIdList></Reference><Reference><Citation>Arisi GM. Nervous and immune systems signals and connections: cytokines in hippocampus physiology and pathology. Epilepsy Behav. (2014) 38:43&#x2013;7. doi: 10.1016/j.yebeh.2014.01.017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2014.01.017</ArticleId><ArticleId IdType="pubmed">24534466</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelghani M, Alsadik M, Abdelmoaty A, Atwa S, Said A, Hassan M. Sleep disturbances following recovery from COVID-19: a comparative cross-sectional study in Egypt. East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. (2022) 28:14&#x2013;22. doi: 10.26719/emhj.22.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.26719/emhj.22.006</ArticleId><ArticleId IdType="pubmed">35165874</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderlind WM, Rabinovitz BB, Miao IY, Oberlin LE, Bueno-Castellano C, Fridman C, et al. . A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr Opin Psychiatry. (2021) 34:420&#x2013;33. doi: 10.1097/YCO.0000000000000713, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YCO.0000000000000713</ArticleId><ArticleId IdType="pmc">PMC8183238</ArticleId><ArticleId IdType="pubmed">34016818</ArticleId></ArticleIdList></Reference><Reference><Citation>EPRS  (2021). European parliamentary research service. The informal economy and coronavirus in Latin America. Available at: https://www.europarl.europa.eu/thinktank/en/document/EPRS_BRI(2021)690587 (Accessed August 22, 2023).</Citation></Reference><Reference><Citation>OECD  (2020). Policy responses to coronavirus (COVID-19). COVID-19 in Latin America and the Caribbean: an overview of government responses to the crisis. Available at: https://www.oecd.org/coronavirus/policy-responses/covid-19-in-latin-america-and-the-caribbean-an-overview-of-government-responses-to-the-crisis-0a2dee41/ (Accessed August 22, 2023).</Citation></Reference><Reference><Citation>Jorge WB, United Nations Development Programme. Camacho A, Del Carpio XV, Hern&#xe1;ndez P, Mel&#xe9;ndez M, et al. . (2022). Long COVID: the extended effects of the pandemic on labor Markets in Latin America and the Caribbean. World Bank. Available at: https://documents.worldbank.org/en/publication/documents-reports/documentdetail/099900007072289098/P1758390cd83e707b0845f0450936b8882b (Accessed February 10, 2023).</Citation></Reference><Reference><Citation>Cid C, Marinho M. L. (2022). Dos a&#xf1;os de pandemia de COVID-19 en Am&#xe9;rica Latina y el Caribe: reflexiones para avanzar hacia sistemas de salud y de protecci&#xf3;n social universales, integrales, sostenibles y resilientes. CEPAL.</Citation></Reference><Reference><Citation>Hiser SL, Fatima A, Ali M, Needham DM. Post-intensive care syndrome (PICS): recent updates. J Intensive Care. (2023) 11:23. doi: 10.1186/s40560-023-00670-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-023-00670-7</ArticleId><ArticleId IdType="pmc">PMC10202754</ArticleId><ArticleId IdType="pubmed">37221567</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanwani-Nanwani K, L&#xf3;pez-P&#xe9;rez L, Gim&#xe9;nez-Esparza C, Ruiz-Barranco I, Carrillo E, Arellano MS, et al. . Prevalence of post-intensive care syndrome in mechanically ventilated patients with COVID-19. Sci Rep. (2022) 12:7977. doi: 10.1038/s41598-022-11929-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11929-8</ArticleId><ArticleId IdType="pmc">PMC9105588</ArticleId><ArticleId IdType="pubmed">35562379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley H, Skorniewska Z, Harrison PJ, Taquet M. Risks of neurological and psychiatric sequelae 2 years after hospitalisation or intensive care admission with COVID-19 compared to admissions for other causes. Brain Behav Immun. (2023) 112:85&#x2013;95. doi: 10.1016/j.bbi.2023.05.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.05.014</ArticleId><ArticleId IdType="pmc">PMC10228171</ArticleId><ArticleId IdType="pubmed">37263366</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda DAP, Gomes SVC, Filgueiras PS, Corsini CA, Almeida NBF, Silva RA, et al. . Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans R Soc Trop Med Hyg. (2022) 116:1007&#x2013;14. doi: 10.1093/trstmh/trac030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trac030</ArticleId><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference><Reference><Citation>Tausch A, e Souza RO, Viciana CM, Cayetano C, Barbosa J, Hennis AJM. Strengthening mental health responses to COVID-19 in the Americas: a health policy analysis and recommendations. Lancet Reg Health Am. (2022) 5:100118. doi: 10.1016/j.lana.2021.100118, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100118</ArticleId><ArticleId IdType="pmc">PMC8782269</ArticleId><ArticleId IdType="pubmed">35098200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zila-Velasque JP, Grados-Espinoza P, Coba-Villan N, Quispe-Chamorro J, Taipe-Guill&#xe9;n YF, Pacheco E, et al. . Mental disorders and level of resilience in eight high-altitude cities of Peru during the second pandemic wave: a multicenter population-based study. Int J Environ Res Public Health. (2023) 20:519. doi: 10.3390/ijerph20010519, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010519</ArticleId><ArticleId IdType="pmc">PMC9819186</ArticleId><ArticleId IdType="pubmed">36612841</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Condoy JS, Fernandez-Naranjo R, Vasconez-Gonz&#xe1;lez E, Cordovez S, Tello-de-la-Torre A, Paz C, et al. . Long COVID at different altitudes: a countrywide epidemiological analysis. Int J Environ Res Public Health. (2022) 19:14673. doi: 10.3390/ijerph192214673, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192214673</ArticleId><ArticleId IdType="pmc">PMC9690364</ArticleId><ArticleId IdType="pubmed">36429392</ArticleId></ArticleIdList></Reference><Reference><Citation>Savovi&#x107; J, Turner RM, Mawdsley D, Jones HE, Beynon R, Higgins JPT, et al. . Association between risk-of-bias assessments and results of randomized trials in cochrane reviews: the ROBES meta-epidemiologic study. Am J Epidemiol. (2018) 187:1113&#x2013;22. doi: 10.1093/aje/kwx344, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx344</ArticleId><ArticleId IdType="pmc">PMC5928453</ArticleId><ArticleId IdType="pubmed">29126260</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva FCT, Neto MLR. Psychiatric symptomatology associated with depression, anxiety, distress, and insomnia in health professionals working in patients affected by COVID-19: a systematic review with meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. (2021) 104:110057. doi: 10.1016/j.pnpbp.2020.110057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.110057</ArticleId><ArticleId IdType="pmc">PMC7411383</ArticleId><ArticleId IdType="pubmed">32777327</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatun A, Tamilanban T, Chitra V. Psychiatric manifestations of COVID-19: a literature review. CNS Neurol Disord Drug Targets. (2023) 22:892&#x2013;905. doi: 10.2174/1871527321666220701152821</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527321666220701152821</ArticleId><ArticleId IdType="pubmed">35786340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>